GAIN THERAPEUTICS INC. - COMMON STOCK
2.5700
18-2月-25 11:42:01
15 分の遅延
株式
-0.1600
-5.86%
本日の幅
2.5600 - 2.8100
ISIN
N/A
ソース
NASDAQ
-
Gain Therapeutics Reports Full Year 2022 Financial Results and Business Update
23 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
22 3 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
21 3 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in the Oppenheimer 33rd Annual Healthcare Conference
09 3 2023 08:00:03 提供 Nasdaq GlobeNewswire
-
27 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate in Upcoming Scientific and Medical Conferences
02 2 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics to Present at Sidoti Small-Cap Virtual Investor Conference
12 1 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Business Update
10 11 2022 16:02:00 提供 Nasdaq GlobeNewswire
-
26 9 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics Announces Promotion of Matthias Alder to Chief Executive Officer
20 9 2022 07:30:00 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics to Present Data at Upcoming Medical Meetings
08 9 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics To Participate At The H.C. Wainwright 24th Annual Global Investment Conference
06 9 2022 08:00:03 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics, Inc. Reports Second Quarter 2022 Financial Results and Business Update
08 8 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate at the 2022 BTIG Biotechnology Conference
04 8 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate at the Jefferies Healthcare Conference
02 6 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics to Participate at the H.C. Wainwright Global Investment Conference
18 5 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Gain Therapeutics, Inc. Reports First Quarter 2022 Financial Results and Business Update
16 5 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
11 5 2022 09:30:00 提供 Nasdaq GlobeNewswire
-
06 5 2022 08:00:00 提供 Nasdaq GlobeNewswire